The global postoperative pain management market is expected to grow at a compound annual growth rate of 5.4 percent between 2017 and 2023, according to a report by Market Research Future.
Teva Pharmaceutical Industries, Eli Lilly, Pfizer, Johnson & Johnson, Purdue Pharma, Endo Pharmaceuticals, Forest Laboratories, GlaxoSmithKline, F. Hoffmann-La Roche, Baxter International and Valeant Pharmaceuticals International are some of the major players in the global postoperative pain management market.
Postoperative pain management decreases the likelihood of pulmonary, cardiac and neuropathic pain complications and aids in minimizing the cost of hospital stay. An increasing number of surgeries and greater demand for pain management treatment drives this market's growth.
More articles on anesthesia:
FDA declares kratom unsafe 'opioid,' supporters of kratom disagree: 6 insights
FDA releases revised opioid blueprint to educate prescribers, mitigate opioid crisis: 4 takeaways